FDG-PET for a thyroid MALT lymphoma

Acta Oncologica

Volumn 47, Issue 6, 2008, Pages 1165-1167

  Lee, Chao Jen ^a   Hsu, Chung Huei ^a   Tai, Cheng Jeng ^a   Lin, Sey En ^a  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; B CELL LYMPHOMA; CANCER INVASION; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYROIDECTOMY;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THYROID NEOPLASMS;

EID: 51149115775     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701732923     Document Type: Letter

References (20)

1. Liu JD, Tai CJ, Chang CC, Lin YH, Hsu CH. FDG-PET in a patient with gastric MALT lymphoma. Acta Oncol 2006;45:750-2.
2. 18F] FDG PET in gastric Non-Hodgkin's lymphoma. Acta Oncol 1997;36:577-84.
3. Hoffmann M, Kletter K, Diemling M, Becherer A, Pfeffel F, Petkov V, et al. Positron emission tomography with fluorine-18-2-fluoro-deoxyglucose (F18-FDG) dose not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Ann Oncol 1999;10:1185-9.
4. Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: A report of 42 cases. Ann Oncol 2005;16:473-80.
5. Hoffmann M, Wöhrer S, Becherer A, Chott A, Streubel B, Kletter K, et al. F18-Floro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: Histology makes the difference. Ann Oncol 2006;17:1761-5.
6. Thieblemont G, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 2002;87:105-11.
7. Holm L, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985;312:601-4.
8. Kato I, Tajima K, Suchi T, Aozasa K, Matsuzuka F, Kuma K, et al. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 1985;76:1085-90.
9. Derringer GA, Thompson LDR, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: A clinicopathologic study of 108 cases. Am J Surg Pathol 2000;24:623-39.
10. Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 2006;15:2069-77.
11. Sasai K, Yamabe H, Haga H, Tsutsui K, Dodo Y, Ishigaki T, et al. Non-Hodgkin's lymphoma of the thyroid-a clinical study of twenty-two cases. Acta Oncol 1996;35:457-62.
12. Chen YK, Chen YL, Cheng RH, Yeh CL, Lee CC, Hsu CH. The significance of FDG uptake in bilateral thyroid glands. Nucl Med Commun 2007;28:117-22.
13. 18F-FDG uptake in the thyroid gland. J Nucl Med 2007;48:896-901.
14. Schmid DT, Kneifel S, Stoeckli SJ, Padberg BC, Merrill G, Goerres GW. Increased F18-FDG uptake mimicking thyroid cancer in a patient with Hashimoto's thyroiditis. Eur Radiol 2003;13:2119-21.
15. Chander S, Zingas AP, Bloom DA, Zak IT, Joyrich RN, Getzen TM. Positron emission tomography in primary thyroid lymphoma. Clin Nucl Med 2004;29:572-3.
16. Puget G, Trampal C, Calvo N, Carrera MJ, Conangla M, Sitges-Serra A, et al. Thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma concurrently diagnosed with a diffuse large B cell lymphoma localized in the neck. Leuk Lymphoma 2007;48:425-7.
17. Lin EC. FDG PET/CT for assessing therapy response in primary thyroid lymphoma. Clin Nucl Med 2007;32:152-3.
18. Mikosch P, Würtz FG, Gallowitsch HJ, Kresnik E, Lind P. F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroid. Wien Med Wochenschr 2003;153:89-92.
19. Androulaki A, Syriou V, Lazaris AC, Paterakis T, Pikazis D, Papathomas T, et al. Maltomas of the thyroid and Sjögren's syndrome in a woman with Hashimoto's thyroiditis. Endocr Pathol 2006;17:89-94.
20. Marchesi M, Biffoni M, Biancari F. False-positive finding on F18-FDG PETafter chemotherapy for primary diffuse large B-cell lymphoma of the thyroid: A case report. Jpn J Clin Oncol 2004;34:280-1.